Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             43 results found
no title author magazine year volume issue page(s) type
1 Application of 3-D Printed Kidney Model in Partial Nephrectomy for Predicting Surgical Outcomes: A Feasibility Study Kyung, Yoon Soo

17 5 p. e878-e884
article
2 A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC) Shah, Ruchitbhai

17 5 p. 356-365.e1
article
3 Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy Weprin, Samuel A.

17 5 p. e1054-e1059
article
4 Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis Barata, Pedro C.

17 5 p. 366-372
article
5 A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer Knipper, Sophie

17 5 p. 395-401
article
6 Bladder Perivascular Epithelioid Cell Tumor: Dynamic CT and MRI Presentation of 2 Cases With 2-year Follow-up and Review of the Literature Xuesong, Du

17 5 p. e916-e922
article
7 Chemotherapy Toxicity Confirms Diagnosis of Urachal Carcinoma Maslov, Diana V.

17 5 p. e913-e915
article
8 Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series Casuscelli, Jozefina

17 5 p. 373-379.e4
article
9 Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors Verbiest, Annelies

17 5 p. e981-e994
article
10 Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis Chen, Chenglong

17 5 p. 319-331
article
11 Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes Su, Shiqiang

17 5 p. e1048-e1053
article
12 Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer Preisser, Felix

17 5 p. e939-e945
article
13 Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors Palumbo, Carlotta

17 5 p. e1026-e1035
article
14 Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study O’Reilly, David

17 5 p. e886-e887
article
15 Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program Saad, Fred

17 5 p. 348-355.e5
article
16 Editorial Board
17 5 p. A5
article
17 Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer Fujiwara, Maki

17 5 p. e923-e929
article
18 Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non–Muscle-Invasive Bladder Cancer in Real-World Clinical Practice Murakami, Kaoru

17 5 p. e1003-e1010
article
19 Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant van Nuland, Merel

17 5 p. e893-e896
article
20 Folic Acid: A New Weapon for Mucositis? Alkan, Ali

17 5 p. e885
article
21 Genomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant Histology Narayan, Vikram M.

17 5 p. e888-e892
article
22 High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy Hapakova, Nikola

17 5 p. e1020-e1025
article
23 Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation Beulque, Yana

17 5 p. e909-e912
article
24 Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature Vitale, Maria Giuseppa

17 5 p. e903-e908
article
25 Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy Watanabe, Keitaro

17 5 p. e897-e902
article
26 Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program Liao, Xinyang

17 5 p. e968-e980
article
27 Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index De Nunzio, Cosimo

17 5 p. 402-407
article
28 New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes Di Nunno, Vincenzo

17 5 p. e871-e877
article
29 Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy Huang, Haichao

17 5 p. e1036-e1047
article
30 Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer Stangl-Kremser, Judith

17 5 p. 389-394
article
31 Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 Marandino, Laura

17 5 p. 332-347.e2
article
32 Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry Sung, John M.

17 5 p. e995-e1002
article
33 Radical Prostatectomy Sociodemographic Disparities Based on Hospital and Physician Volume Omidele, Olamide O.

17 5 p. e1011-e1019
article
34 Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study Schmidinger, Manuela

17 5 p. e957-e967
article
35 Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study Natale, Caleb

17 5 p. 380-388
article
36 Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? Tay, Kae Jack

17 5 p. e930-e938
article
37 Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands Westgeest, Hans M.

17 5 p. e946-e956
article
38 Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer Haque, Waqar

17 5 p. e1069-e1079
article
39 Table of Contents
17 5 p. A7-A13
article
40 The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis Sun, Yi

17 5 p. e847-e859
article
41 Transperineal Magnetic Resonance Imaging–Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer: Systematic Review and Meta-analysis Tu, Xiang

17 5 p. e860-e870
article
42 Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study Konishi, Sakae

17 5 p. e1080-e1089
article
43 Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer Tan, Wei Shen

17 5 p. e1060-e1068
article
                             43 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands